AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2008
Mar 21, 2008
30786_dirs_2008-03-21_167bdf28-7ba0-4140-a234-1fb7ffdcf78d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2005-02-09
Reporting Person: SCHWARTZ DAVID (Director, Chairman of the Board, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-02-09 | Incentive Stock Option (right to buy) | $62.04 | A | 1773 | Acquired | 2010-02-09 | Bio-Rad B Common Stock (1773) | Direct |
| 2005-02-09 | Non-Qualified Stock Option (right to buy) | $56.40 | A | 8227 | Acquired | 2015-02-09 | Bio-Rad B Common Stock (8227) | Direct |
Footnotes
F1: The number of shares subject to this stock option grant was incorrectly split between incentive and non-qualified stock options on the Form 4 as originally filed, although the combined total number of shares for the two types of options included in this grant was reported correctly.
F2: The stock option vests over five years at 20% per year beginning one year from the grant date.
F3: The expiration date was incorrectly stated on the Form 4 as originally filed.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13